Open tender · Germany · Pharmaceutical products
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Dabigatran (ausschl. in der Normgröße N3), ATC B01AE07 f. d. Z. 01.7.26 - 30.6.28 (zzgl. V.-Option 1x12 Mon)
In EnglishConclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Dabigatran (excluding standard size N3), ATC B01AE07 for the period 01.07.26 - 30.06.28 (plus extension option 1x12 months)
DAK-Gesundheit in Germany is inviting bids for “Conclusion of a non-exclusive discount agreement under § 130a para. 8 SGB V for the active ingredient Dabigatran (excluding standard size N3), ATC…”. Bids close on 5 May 2029, 12:00 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Framework agreement for drug rebates on Dabigatran (ATC B01AE07, norm size N3) for DAK health insurance.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 0 requirements to qualify and the 4 documents a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences